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Polymer/bioactive glass composites are getting more interest nowadays in bone tissue 
engineering and orthopedic applications where polymers are used as matrix material and 
bioactive glasses are used as either filler material or as coating. The idea of combining 
bioactive glasses with biodegradable polymers is to develop composites that takes an ad-
vantages of osteoconductive properties of bioactive glasses and their strengthening effect 
on polymer matrices. Such composites are expected to have superior mechanical proper-
ties than the neat unreinforced polymer and to improve structural integrity and flexibility 
over brittle glasses for eventual load-bearing applications. 
The thesis is based on composites consisting of PLA 70/30 as matrix polymer and bioac-
tive glass as a filler material prepared by twin-screw extrusion method. The polymer ma-
trix was combined with different weight percent of silicate and phosphate based bioactive 
glasses. Fourier Transform Infrared Spectroscopy (FTIR) was used to analyze the surface 
and structural changes in the composites upon immersion in the buffer solution. Mass 
change, water uptake measurement and FTIR indicates that with increasing the filling 
content the water absorption was increased. The changes were more drastic with the phos-
phate based composites compared to the silicate one. Ca release profile was analyzed by 
Atomic Absorption Spectroscopy (AAS) and was found to increase with immersion time.  
The mechanical properties of all investigated glasses were found to first decrease, as ex-
pected upon degradation of the composite. However, the bending strength increased after 
two weeks of immersion was unexpected, especially since the shear strength was not 
found to greatly change over the course of the test, and calls for more in-depth analysis. 
Finally, molecular weight of the polymer was found to decrease upon immersion up to 
two weeks and remained stable for longer immersion time in silicate based composite 
while in case of phosphate based composites, molecular weight was found to increase 
drastically after two weeks of immersion, raising the question of the impact of P release 
on the cross linking of the polymer chains. Overall a 30 weight % of glass within the 
composite was found to be optimum to maintain high mechanical properties, ductility, 
while providing significant Ca release, promising indication of the bioactivity.  
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1. INTRODUCTION 
Biodegradable polymers can be defined as materials whose physical and chemical prop-
erties undergo deterioration and complete degradation when exposed to biological envi-
ronment. The degradation products of such polymer are excreted through the normal met-
abolic activity of living system. Biodegradable polymers has been widely used in medical 
application such as degradable suture, controlled drug delivery, coating on metallic im-
plant etc. (Babu et al. 2013) Among many biodegradable polymers, Poly lactic Acid 
(PLAs) are commercially available interesting thermoplastic polymers which has many 
unique characteristics such as good transparency, glossy appearance, high rigidity and 
ability to tolerate various types of processing conditions. PLAs belongs to the family of 
aliphatic polyesters with the basic constitutional unit being lactic acid. The lactic acid 
monomer, the hydroxyl carboxylic acid, can be obtained through bacterial fermentation 
from corn (starch) or sugars that are obtained from renewable resources. PLA can be 
synthesized from lactic acid by direct polycondensation reaction or ring-opening 
polymerization of lactide monomer (Babu et al. 2013). Despite its unique properties, it 
lacks the osteoconductive and bioactive feature which limits its application in orthopedic 
application.  
Bioceramics are a class of ceramics which are used for repair and replacement of diseased 
and damaged parts of musculoskeletal systems. Bioceramics have been used for medical 
applications, mainly for implants in orthopedics, maxillofacial surgery and for dental im-
plants. Some bioceramics, like bioactive glass and β- tricalcium phosphate (β-TCP), have 
capability of forming direct chemical bonds with bone or even with soft tissue of a living 
organism. (Thamaraiselvi & Rajeswari et al.2004). However, the brittleness and low frac-
ture toughness of bioactive glass limits its application in load bearing application in the 
biomedical field. 
Although, fabrication of polymers into complex shapes and porous structures is easy, they 
lack a bioactive function and are too flexible and weak to meet the mechanical demands 
in bone regeneration which limits their application in orthopedic application while on 
other side, the brittle nature of bioactive glass has limited the application in loadbearing 
application regardless of its bioactive nature. So, to overcome the limitations of both pol-
ymer and bioactive glass, the idea of bioactive glass and polymer composite has been 
developed. By combination of bioactive bioceramic and biodegradable polymer, oste-
oconductive and bioresorbable composite with tailored mechanical properties and ease of 
shaping can be developed. 
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The thesis is based on composites which were prepared by combining PLA 70/30 with 
different weight percent (wt. %) of silicate (13-93) and phosphate (Strontium 50) based 
bioactive glass. The rod-shaped composite was prepared by twin screw extrusion method. 
TRIS buffer was used as dissolution solution for in vitro test series. The aim of this thesis 
was to compare the mechanical and hydrolytic behavior of different composite samples 
at different immersion time point. In vitro properties of sample were analyzed in terms of 
change in pH, mass loss, water absorption and mechanical testing (3-point bending and 
shear test). Composites were also characterized using Fourier Transform Infrared Spec-
troscopy (FTIR), Atomic Absorption Spectroscopy (AAS), Gel Permeation Chromatog-
raphy (GPC) and Thermogravimetric Analysis (TGA). Characterization of different com-
posite should help in defining the most suited bioactive glass type and filler content to 
tailor properties based on the desired applications. 
In this thesis, an in-depth literature review has been conducted and is presented in Chapter 
2. In the literature review, bioactive glass, biodegradable polymer, polymer/glass compo-
sites and advantages and disadvantages of polymer and glass have been discussed. Special 
attention has been brought to the state of the art on polymer/glass composite. Impact of 
glass compositions and filler content on various properties of the composites are dis-
cussed. Chapter 3 reports the materials and method. In this section the glass and polymer 
types studied along with the preparation methods and characterization techniques em-
ployed are described. The main results obtained over the course of the thesis are reported 
and discussed in Chapter 4. The main conclusions are reported in Chapter 5. 
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2. LITERATURE REVIEW 
 Bioceramics 
Bioceramics are groups of ceramics that are commonly used for the repair and reconstruc-
tion of diseased or damaged parts of the musculoskeletal system. Bioceramics may be 
bioinert such as alumina and zirconia. They can be resorbable like tricalcium phosphate, 
or bioactive like hydroxyapatite, bioactive glasses, and some glass-ceramics. Bioceramics 
are used as bulk materials as in the case of hip implant or as porous structure (scaffolds 
or coatings) when tissue ingrowth and firm bond with tissue are required. Bioceramics 
have been used in replacements for hips, knees, teeth, tendons, and ligaments and repair 
for periodontal disease, maxillofacial reconstruction, augmentation and stabilization of 
the jaw bone, spinal fusion, and bone repair after tumor surgery. (Hench, 1998) We will 
focus more on resorbable and bioactive bioceramics in the following section. 
2.1.1 Bioactive glass 
Bioactive glasses were introduced by Hench in the early 1970s. A bioactive material has 
been defined as a material that has been designed to induce specific biological activity 
(Williams, 2009). Bioactive material undergoes specific surface reactions, when im-
planted into the body, leading to the formation of hydroxyapatite (HA), a layer that is 
responsible for the formation of a firm bond with hard and soft tissues (Kokobu et 
al.2006). The ability of a material to form an HA-like surface layer when immersed in 
simulated body fluid (SBF) is often taken as an indication of its bioactivity. This in vitro 
bioactivity is an indication of the bioactive potential of a material in vivo (Rahaman et al. 
2011). 
Bioactive glass is mainly composed of silicon dioxide, sodium oxide, calcium oxide and 
phosphorous pentoxide which are physiological chemicals found in the body. The bone-
bonding reaction results from a series of reactions between the glass and its surface. 
(Hench and Andersson, 1993). When bioactive glass granules are inserted into bone de-
fects, ions are released in the body fluids and precipitate into a bone-like apatite at the 
granule surface which promotes the adhesion and proliferation of osteogenic cells. The 
material will, soon thereafter, be replaced by new bone. The first step of the glass/solution 
interactions can be summarized as follow: 
1) Leaching and formation of silanols: The glass network releases alkali elements cat-
ions such as Ca+2, Na+, K+, etc. The exchange of cations releasing of glass occurs with H+ 
or H3O
+ cations proceeding from the solution makes the solution more alkaline resulting 
in higher value of interfacial pH, usually more than 7.4.  
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2) Dissolution of the glass network: The breakage of –Si-O-Si-O-Si- bonds through the 
action of hydroxyl ions leads to dissolution of glass network. This Breakdown of the silica 
network releases silic-acid [Si (OH) 4]. The rate of dissolution of silica highly depends on 
glass composition. Presence of more than 60% of silica in glass decreases the dissolution 
rate due to the larger number of bridging oxygen bonds in the glass structure. The hy-
drated silica (SiOH) formed on the glass surface by these reactions undergoes rearrange-
ment by polycondensation of neighbouring silanols, resulting in a silica rich gel layer. 
3) Precipitation: Calcium and phosphate ions are released from the glass together with 
those already present in the solution, form a calcium-phosphate rich layer (CaP) at the 
material surface. This calcium-phosphate layer is initially amorphous and later on crys-
tallizes into hydroxycarbonate apatite (HCA). The mechanism of nucleation and growth 
of HCA appears to be the same in-vivo and in vitro and is accelerated by the presence of 
hydrated silica.  
The precipitation of the HCA layer is then followed by reaction between the new formed 
reactive layer and the biological environment as shown in Figure 1. The HCA formation 
is followed by biochemical adsorption and desorption of growth factors and macrophages 
required to prepare the implant site for tissue repair are activated. Then, attachment of 
stem cells and synchronized proliferation and differentiation of the cells, rapidly occurs 
on the surface of bioactive materials. After that, bioactive materials begin to produce var-
ious growth factors which stimulate cell division, mitosis, and production of extracellular 
matrix proteins. Finally, mineralization of matrix results in mature osteocytes. (Hench, 
2013) 
 
Figure 1: Sequence of interfacial reactions involved in forming a bond between bone 
and a bioactive glass (Gerhardt et al. 2010) 
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The advantage of bioactive glass is that it is possible to design the glass to get a controlled 
rate of degradation and bonding to the tissue. The rate of degradation should be tailored 
in order to match the speed of the tissue healing. It is noteworthy that tissue healing time 
can vary greatly based on the tissue to be healed, the age of the patient and the mechanical 
constraint at the surgical site post-surgery. (Hench and Andersson, 1993) 
The major disadvantage of bioactive glass is its high modulus and brittle nature. The brit-
tleness and low fracture toughness limits its application in the biomedical field. Low frac-
ture toughness refers to ability to resist fracture when a crack is present. Thus, bioactive 
glasses cannot be used for load-bearing implants. Especially, the repair and regeneration 
of large bone defects at load-bearing anatomical sites such as limbs is a great challenge 
for bioactive glass (Gerhardt et al. 2010) Although, bioactive glass are strong enough to 
function in stress bearing sites in the head and mandible replacement, they cannot be used 
in orthopedics. This is because, bioactive glass cannot be easily contoured in the operating 
room and screws cannot be easily placed into bioactive glass blocks because they resist 
drilling and have a tendency to fragment during creation of screw holes. (Nandi et al. 
2011) 
Most commonly studied bioactive glasses types are silicate, phosphate and borate based 
bioactive glass. Brief description of all types of bioactive glass is discussed below: 
a) Silicate based bioactive glass 
The most widely investigated bioactive glass composition is the bioactive silicate “45S5 
Bioglass®”, which has a composition (in wt. %) of 45% SiO2, 24.5% Na2O, 24.5% CaO, 
and 6% P2O5. The key compositional features that are responsible for the bioactivity of 
45S5 glass is its low SiO2 content while comparing to other more chemically durable 
silicate glasses with high Na2O and CaO content and high CaO/P2O5 ratio. (Rahaman et 
al. 2011) They offer remarkable advantages as the inorganic components of composite 
scaffolds due to their high bioactivity index. Indeed, this glass is rated Class A bioactive 
material, i.e. it has the ability to bond to both soft and hard connective tissues. Although, 
45S5 glass remains the gold standard for bioactive glass some limitations exist, limiting 
in some case their clinical use. For instance, the low Si content of this glass along with 
its high alkali and alkaline earth content leads to a silicate structure prone to crystalliza-
tion upon heating. Thus this glass cannot be sintered into porous scaffolds without crys-
tallization. (Rahaman et al. 2011) (Massera et al, 2012) 
Similarly, the use of “S53P4” bioactive glass (BonAlive Biomaterials Ltd., Turku, Fin-
land), with the specific composition (in wt. %) of 53% SiO2, 4% P2O5, 23% Na2O, and 
20% CaO is increasing in clinical practice in various bone graft applications and in treat-
ment of osteomyelitis. S53P4 bioactive glass is indicated to facilitate and stimulate bone 
formation and bone defect healing and is also supposed to have an antibacterial effect in 
various applications. S53P4 bioactive glass is mostly used in a granular form (0.8–
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3.15 mm). (Van Gestel et al. 2015). However as for the glass 45S5 the hot working do-
main is rather low whereas the crystallization rate is high at typical sintering temperature 
(Massera et al. 2012). The “13-93” bioactive glass is another silicate glass that is receiv-
ing more attention nowadays. This glass has a higher SiO2 content (53 wt. %) than 45S5 
Bioglass®. (Tournie et al.2013) The higher Si along with lower Na content makes this 
glass promising for scaffold manufacturing. Furthermore, the structural changes lead to a 
slower dissolution rate in vitro, which could be beneficial for the healing of large defects 
in bones. (Massera et al. 2012).  
 
b) Phosphate based bioactive glass 
Phosphate based glasses were considered to dissolve rapidly in aqueous media. However, 
some studies have demonstrated that phosphate glass structure can be modified to reach 
dissolution rates similar to those of silicate glasses (Bunker et al 1984). Phosphate glasses 
can be used in various applications such as nuclear waste management (Day, et al. 1998), 
hermetic seals (Brow et al. 1996) or high power lasers (Weber et al 1990) by tailoring its 
dissolution rate. Phosphate based glasses have been found to be good alternatives to sili-
cate glasses in many biomedical applications, such as bone repair and reconstruction 
(Clement et al. 1990 & Knowles et al. 2003) Phosphate glass fibers for medical applica-
tions have been drawn by melt processing and have been found promising in soft tissue 
engineering applications. (Massera et al. 2014) 
Recently a phosphate bioactive glass containing strontium and labelled SR50 was devel-
oped. (Massera et al.2013) Physiologically, strontium and calcium are similar. They are 
both absorbed in the gastrointestinal tract, concentrated in bone and excreted primarily in 
urine. The mechanisms of strontium incorporation into bone, involves ionic exchange 
with bone calcium. Strontium is currently used in bone therapies. Strontium ranelate (SR) 
is marketed under the name of Protelos, Osseor, Protos, Bivalos, Protaxos and Ossum, 
and used to treat osteoporosis. It has been shown that SR strengthens bone, increases bone 
mass and density and lessens the possibility of vertebral and hip fracture in elderly 
women. (Abou Neel et al.2009). 
Phosphate glasses have the advantage over silicate bioactive glasses to have a congruent 
dissolution. Indeed, as mentioned earlier the dissolution of bioactive silicate glasses is 
primarily governed by the leaching of alkaline and alkaline earth ions within the solution 
while the Si is leached at lower rate forming a Si-rich gel. In the case of phosphate bio-
active glasses, all ions in the glass network leach out at a similar rate and the surface of 
the glass does not change significantly its composition. As no gel layer is formed, the 
dissolution of phosphate based glass is more sustained over time (Khan et al. 2010) 
(Massera et al. 2014) (Bunker et al 1984) 
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c) Borate based bioactive glass  
Recently, interest in borate glasses has increased largely due to very encouraging clinical 
results of healing of chronic wounds, such as diabetic ulcers, that would not heal under 
conventional treatment (Jones, 2012). The soft tissue response may be due to their fast 
dissolution, which is more rapid than that for silica based glasses. Borate bioactive glasses 
have shown to support cell proliferation and differentiation in vitro as well as tissue infil-
tration in vivo (Rahaman et al. 2011). Also, recent work has shown that by varying the 
composition of bioactive glass, its degradation rate can be controlled such as by partially 
replacing the SiO2 in silicate 45S5 glass with B2O3, the rate of degradation can be varied 
over a wide range. (Huang et al. 2006) 
2.1.2 Calcium phosphate ceramics 
Many implantations failed earlier because of infection as well as due to lack of knowledge 
about the toxicity of the selected materials. The use of calcium phosphates is reasonable 
due to their similarity to the mineral phase of bone and teeth and are easily accepted by 
human body. (Sakka et al. 2013). Calcium phosphate based biomaterials and bioceramics 
are now used in a number of different applications throughout the body, covering all areas 
of the skeleton. The different forms of commercially available calcium phosphates cur-
rently used in the biomedical industry are hydroxyapatite, β- tricalcium phosphate (β-
TCP), α-tricalcium phosphate (α-TCP), biphasic calcium phosphate, monocalcium phos-
phate monohydrate and unsintered apatite. (Nor et al. 2009)  
β-tricalcium phosphate (β-TCP) is used in various orthopedic applications due to its os-
teoconductive and biodegradable nature. Although β-TCP has several favorable proper-
ties, it cannot be used in many loadbearing applications because of its poor mechanical 
properties (brittle in nature) and poor fatigue resistance. (Sakka et al. 2013) Hence, β-
TCP have been combined with other calcium phosphate like HA in order to improve its 
mechanical property. HA is very stable but has low osteoconductivity. Combination of 
both develops biphasic calcium phosphate (BCP) which is supposed to overcome the lim-
itations of each material. Several studies have demonstrated that BCPs can be used as 
bone substitutes successfully. (Lee et al. 2015) 
 
 Biodegradable polymer 
Biodegradable polymers are the polymers that are degraded in vivo either enzymatically 
or non-enzymatically. By-products produced by such polymers are biocompatible and 
toxicologically safe which are further eliminated by the normal metabolic pathways 
(Makadia and Siegel, 2011). The American Society of Testing and Materials (ASTM) 
defines 'biodegradability' as: "capable of undergoing decomposition into carbon dioxide, 
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methane, water, inorganic compounds, or biomass in which the predominant mechanism 
is the enzymatic action of microorganisms, that can be measured by standardized tests in 
a specified period of time, reflecting available disposal conditions." 
Biodegradable polymers have been used in different implants, eliminating the need of 
additional surgery to remove the implant. They are also supposed to be ideal for drug 
delivery application in which the implant should degrade and disappear over time. Since 
they are biocompatible, non-toxic in nature and its degradation rate can be controlled, 
they have been used extensively in the biomedical field. Beside this, they can also be 
fabricated into various shapes with desired pore morphologic features favorable to tissue 
in-growth. Furthermore, biodegradable polymers can be designed with specific chemical 
functional groups that can induce tissue in-growth. (Gunatillake & Adhikari, 2003) The 
basic category of biodegradable polymers used in biomedical field can be broadly classi-
fied as natural biodegradable polymers and synthetic biodegradable polymers. 
a) Natural polymers: Natural polymers are formed in nature during the growth cycles 
of all organisms. Natural biodegradable polymers are called biopolymers. The two 
main renewable sources of biopolymers are polysachharides and proteins.  Polysac-
charides such as starch and cellulose, represent the most important family of these 
natural polymers. Natural polymers are often chemically modified in order to improve 
the mechanical properties as well as to modify their degradation rate. (Vroman & 
Tighzert, 2009) Since natural polymers are mostly derived from an animal source, the 
material purity of polymer can often differ from one batch to another. Furthermore, 
there is always a risk of transfer of disease from animal to human (Nair & Laurencin 
2007).  
 
b) Synthetic polymers: Synthetic polymers are produced from non-renewable petro-
leum resources. Biodegradation of polymeric biomaterials involves cleavage of hy-
drolytically or enzymatically sensitive bonds in the polymer leading to polymer ero-
sion. A large number of biodegradable polymers have been synthesized recently and 
some microorganisms and enzymes capable of degrading them have been identified. 
(Ghanbarzadeh & Almasi, 2013) Synthesis of synthetic polymers can be easily ma-
nipulated and the material impurities can be controlled. As a result, the mechanical 
and physical properties of synthetic polymers can be correctly predicted and repro-
duced. (Chen et al. 2008).  
 
The most widely utilized biodegradable synthetic polymer for 3D scaffolds in tissue en-
gineering are saturated aliphatic polyesters, typically poly-α-hydroxy esters such as poly 
lactic acid (PLA), poly glycolic acid (PGA), poly ϵ-caprolactone (PCL) and their copol-
ymers. The chemical properties of these polymers allow hydrolytic degradation through 
de-esterification. After degradation, the lactic and glycolic acid monomers are metabo-
lized naturally by tissues. Due to these properties, PLA, PGA, PCL, and their copolymers 
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have successfully been applied in a number of biomedical devices, such as degradable 
sutures and bone internal fixation devices (BiofixW, Bionx Implants Ltd., Tampere, Fin-
land) which have been approved by the US Food and Drug administration. (Chen et al. 
2012)  
 
2.2.1 Poly lactic Acid (PLA) 
Poly lactic acid belongs to the family of aliphatic polyesters commonly made from acid, 
and are considered as biodegradable and compostable. It is a synthetic biodegradable pol-
yester where the monomer is lactic acid (LA). LA is derived from natural resource which 
is produced by bacterial fermentation of carbohydrates such as corn, sugarcane, potatoes 
and other biomass. (Lim et al. 2007) The chemical structure of Poly lactic acid (PLA) is 
shown in Figure 2.  
 
Figure 2: Chemical Structure of PLA (Averous & Pollet, 2012) 
PLA can exist in two optically active stereoiso-meric forms, L-lactic acid and D-lactic 
acid as shown in Figure 3. L-lactic acid is a naturally occurring isomer. Polymers of L-
lactic acid and D-lactic acid are called PLLA and PDLA respectively (Averous and Pollet, 
2012). PLA can be either amorphous or semicrystalline, depending upon its stereochem-
istry and thermal properties. PLA can be produced totally amorphous or up to 40 % crys-
talline. PLA resins containing more than 93 % of L-lactic acid are semi-crystalline while 
PLA with 50–93 % L-lactic acid is completely amorphous. (Henton et al. 2005) There-
fore, the properties of poly lactic acid, such as melting temperature and crystallinity are 
highly dependent upon ratio of L and D enantiomers (Carrasso et al.2010) 
 
Figure 3: Isomers of Lactic acid (Nampoothiri et al.2010) 
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Commercially available PLA is PDLDA, which is a copolymers of poly (L-lactic acid) 
(PLLA) and poly (D, L-lactic acid) (PDLA). Poly (L-lactide) is characterized by a high 
content of crystals, high strength particles, and prolonged period of degradation. In con-
trast, Poly (DL lactide) is characterized by lower strength and quicker rates of degrada-
tion. PDLDA has a structure that combines the best characteristics of poly (L-lactic acid) 
and poly (D-lactic acid that is, the mechanical properties of the poly(L-lactide) and the 
shorter degradation time of the poly (DL-lactic acid). These properties have made PLDLA 
a compound of great relevance in the controlled release of drugs and in bone tissue engi-
neering. (Masa et al. 2015) 
PLA can be synthesized using three different routes: direct condensation polymerization, 
azeotropic dehydrative condensation, and ring-opening polymerization of lactide. Gener-
ally, PLA produced by these methods are of high molecular weight. Among these three 
methods most commonly used method is ring opening polymerization as shown in Figure 
4. Direct condensation polymerization is the least expensive method, but only low mo-
lecular weight PLA can be produced due to difficulties in removing water. (Jiang & 
Zhang, 2013) 
 
Figure 4: Synthesis of PLA by ROP (Jiang & Zhang, 2013) 
PLA can be considered as a polymer with the broadest range of applications because of 
its ability to be stress crystallized, thermally crystallized, impact modified, filled, copol-
ymerized, and processed in most polymer processing equipment. (Henton et al 2005). 
PLA can be processed into fiber, film, sheet, and 3D articles using different processing 
technologies such as drying, extrusion, injection molding, injection stretch blow molding, 
casting, blown film, thermoforming, foaming, blending, fiber spinning etc. (Jiang & 
Zhang, 2013) 
The typical glass transition temperature (Tg) of PLA ranges from 50 to 80 °C while the 
melting temperature(Tm) ranges from 130 to 180 °C. For example, for enantiomerically 
pure PLA, Tg is 55 °C and Tm is 180 °C. For such semi-crystalline PLA, the Tm is a 
function of the different processing parameters and the initial PLA structure. Tm increases 
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with the molecular weight (Mw) until a maximum value. Besides that, the crystallinity 
decreases with increasing Mw. (Averous and Pollet 2012) The Tg and Tm of PLA are 
strongly affected by overall optical composition, primary structure, thermal history and 
molecular weight. Amorphous PLAs transfer from glassy to rubbery, above Tg and upon 
further heating, it will behave as a viscous fluid. While below Tg, PLA behaves as a glass 
with the ability to creep until cooled to its β transition temperature of approximately -45 
°C. Below this β transition temperature, PLA will only behave as a brittle polymer. 
(Henton et al. 2005) 
PLA readily absorbs moisture from the atmosphere as it is hygroscopic thermoplastic. 
The presence of even small amounts of moisture will hydrolyze PLA in the melt phase, 
reducing the molecular weight. As a result, the mechanical property of PLA is decreased. 
Therefore, PLA must be thoroughly dried prior to melt processing. PLA is generally dried 
at temperature range of 80–100 ◦C. Excessive heat and moisture should be avoided during 
processing of polymer which may lead to thermal and hydrolytic degradation. (Lima et 
al. 2008) 
Most potential applications of PLAs in the medical fields are tissue engineering, wound 
management, drugs delivery, and orthopedic devices. Different types of biodegradable 
screws, fixation pins, plates, and suture anchors have been used as orthopedic device. 
(Hamad et al. 2014) However, most common biomedical application of PLA is Dexton 
fibre which is used as resorbable suture. Fibers can be prepared by either melt spinning 
or solvents pinning method. Fiber prepared by solvent spinning has higher mechanical 
properties in comparison to melt spinning where there are chances of thermal degradation 
(Södergård and Stolt, 2002). PLA is very stable and will retain its molecular weight and 
physical properties for years. Thus, its use in clothing and durable applications is increas-
ing. Also, high molecular weight PLA is also naturally resistant to supporting bacterial 
and fungal growth, which allows it to be safely used for applications such as food pack-
aging and sanitation. (Nampoothiri et al.2010).  
2.2.2 Hydrolytic behavior of Polylactic acid (PLA) 
The degradation mechanism of aliphatic polyesters like PLA, PGA and their copolymers 
is hydrolysis. The chemical structure of such polymers consists carbon-oxygen-carbon 
(C-O-C) bonds in their polymer chain. When such polymer are exposed to water, the 
water molecules react with C-O-C bond resulting in breakage of bond.(Borden 2006) 
However, the degradation mechanism of aliphatic polymers has been found to be depend-
ent on a large number  of factors, such as molecular weight, crystallinity, purity, temper-
ature, pH, presence of terminal carboxyl or hydroxyl groups, water permeability, and ad-
ditives acting catalytically that may include enzymes, bacteria or inorganic fillers (Park 
and Xanthos, 2009, Averous, 2008).  
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For example, crystallinity plays important role in the hydrolysis rate of polymer. The 
crystalline segments in the polymer are more stable than the amorphous segments which 
are responsible for slowing down the hydrolysis rate of polymer. Similarly, polymer with 
longer polymer chains with high molecular weights degrades slowly than those with 
shorter chain with lower molecular weights. Also, chemical structure and composition of 
polymer play important. Some polymer consists of bond that are susceptible to hydrolysis 
than other as well as some groups in polymer backbone which can be either hydrophilic 
or hydrophobic in nature that directly effects on the degradation phenomenon of polymer. 
For instance, PLA consist of methyl group in the backbone which is hydrophobic in na-
ture. Thus PLA degrades more slowly than other aliphatic polymer like PGA. (Li, 1999, 
Middleton & Tipton 2000, Borden 2006, Rezwan et al.2006) 
Polylactides undergo hydrolytic degradation via the bulk erosion mechanism by the ran-
dom scission of the ester backbone. It degrades into lactic acid, a normal human metabolic 
byproduct, which is broken down into water and carbon dioxide via the citric acid cycle. 
The degradation mechanism of PLA starts with hydrolysis, followed by bacterial attack 
on the fragmented residues. The rate of hydrolysis is accelerated by acids or bases and is 
dependent on moisture content and temperature. (Nampoothiri et al.2010)  
The hydrolytic degradation of PLA can be divided into two stages. At ﬁrst, the water 
diﬀuses into the amorphous regions of the polymer with random hydrolytic scission of 
ester bond, which converts the long polymer chains into shorter ones. Because this occurs 
in the amorphous regions there is a reduction in molecular weight but no loss in physical 
properties, while the crystalline regions hold the structure together. In the second stage 
the crystalline regions fragment and the physical properties diminish. Later, the fragments 
are metabolized by enzymes resulting in a rapid loss of polymer mass. (Jiang & Zhang, 
2013, Nair & Laurencin, 2007) 
 Composite 
Composite can be defined as a multiphase material made from a combination of materials, 
differing in composition, which remain bonded together, but retain their identities and 
properties, without going into any chemical reactions. (Agrawal, 1990) Some of the 
unique advantages of composites are its high strength, high stiffness, long fatigue life, 
low density, and adaptability to the intended function of the structure. Also, composites 
materials can be easily moulded into any complex shape. (Agrawal, 1990) Bone is a sim-
ple example of a natural composite material having the best properties of its constituents. 
Bone must be strong and rigid but yet flexible enough to resist breaking under normal 
use. These essential properties are contributed by its components. A mature bone is made 
up of two basic kinds of materials, organic and inorganic. The organic component, con-
sisting mostly of proteins, carbohydrates and fats, makes it pliable and gives the required 
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softness. The inorganic consists mainly of hydroxyapatite (HA) that maintains the me-
chanical strength. (Agrawal, 1990) 
Different material has its identical properties with both advantage and disadvantage. For 
examples: plastics are light, durable, have excellent corrosion resistance and can be easily 
molded to any complex shape but they lack sufficient strength, stiffness and dimensional 
stability. (Harris, 1999) Similarly, ceramics have great thermal stability and are resistant 
to most forms of attack such as abrasion, wear and corrosion. Although ceramics are in-
trinsically very rigid and strong because of their chemical bonding, they are all brittle and 
can be formed and shaped only with difficulty. (Harris, 1999) Hence, different materials 
can be combined to form a composite material with optimum properties. The mechanical, 
biological and physiological properties of such composite can be tailored according to 
required application and are supposed to be superior and unique while comparing the 
properties of individual component. (Huang and Ramakrishna, 2004) 
For an example, although calcium phosphates ceramics are one of the established mate-
rials for the augmentation of bone defects, they exhibit relatively poor tensile and shear 
properties. In practice, the strength of the calcium phosphate cements is lower than that 
of bone, teeth, or sintered calcium phosphate bioceramics and are generally brittle in na-
ture. Hence, calcium phosphate ceramics can be combined with different biodegradable 
polymer to form a composite in order to not only improve the mechanical properties but 
also favor bone healing. (Sakka et al.2002).  
Classification of composite 
Composite material is a multi-phase system whose internal structure consists of three 
basic physical phases called matrix phase, reinforcement phase and composites interface 
phase, as shown in Figure 5. (Daniel and Ishai, 1994). Composite interface phase is the 
interface between the reinforcement phase and the matrix phase. The performance of a 
composite materials is determined by the structure and the nature of these phases, their 
configuration and interaction. (Wang et al.2011) Matrix phase is primary phase having a 
continuous character called matrix. It is usually more ductile and weaker phase that holds 
the dispersed phase and shares a load with it. Matrix material includes metal matrix com-
posite materials, inorganic non-metallic matrix composite materials and polymer matrix 
composites by the different matrix materials. Dispersed phase is the secondary phase that 
is embedded in the matrix in a discontinuous form. Dispersed phase is scattered and sur-
rounded by the matrix and is usually stronger and stiffer than the matrix phase. A dis-
persed phase usually includes fibrous materials such as glass fiber, organic fiber. The 
interphase also plays an important role in controlling the failure mechanisms, fracture 
toughness, and overall stress–strain behavior of the material. Hence, the properties of a 
composite material depend on the properties of the constituents, geometry, and distribu-
tion of the phase. (Harris, 1999, Daniel and Ishai, 1994) The three different phases of 
composite are represented in Figure 5 below. (Daniel and Ishai, 1994) 
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Figure 5: Phases of composite material (Daniel and Ishai, 1994) 
According to the matrix phase, composite is classified as: polymer-matrix composites 
(PMC), metal-matrix composites (MMC), ceramic-matrix composites (CMC) and car-
bon-carbon matrix composites (CCM). Composites can also be classified according to the 
dispersed (reinforcing) phase as particle reinforced composites, short-fiber reinforced 
composites and long-fiber reinforced composites. Long-fiber reinforced composite is fur-
ther classified as unidirectional and woven lamina. (Daniel and Ishai, 1994) In biomedical 
application, the most commonly used is polymer matrix composites (Huang and Rama-
krishna, 2004) 
Polymer matrix composite material is the one that uses organic polymer as matrix and-
fiber as reinforcement. Normally, the strength and modulus of fiber are much higher than 
the matrix material which makes it the main load-bearing component. In addition, matrix 
material is supposed to have good adhesion properties in order to bond fibers together 
firmly. At the same time, the matrix material can serve to uniformly distribute the applied 
load, and transfer the loads to fiber. The properties of composite materials is mainly de-
pendent on the characteristics of the matrix material. As a result, the performance of com-
posite materials is directly influenced by the performance of fiber, matrix and the inter-
face between them. (Wang et al. 2011) Polymer matrix composites include thermoset like 
epoxy, polyimide and polyester, thermoplastic like poly-ether-ether-ketone and polysul-
fone which are reinforced with glass, carbon (graphite), aramid (Kevlar), or boron fibers. 
They are used primarily in relatively low temperature applications. (Daniel and Ishai, 
1994) 
 Composite of glass and polymer  
Glasses have high chemical stability, but they are likely to lose their mechanical strength 
at relatively low temperatures as they pass through the glass transition. The principal 
problem with glassy materials is that they are always brittle and their measured strengths 
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are very variable at ordinary temperatures. Few Polymers are thermally stable in compar-
ison with metals or ceramics. Major disadvantage of polymers is their very low mechan-
ical strength and stiffness in bulk form. (Harris, 1999) 
Various studies have been made in order to compare the property of glass and polymer 
composite in terms of bioactivity and mechanical properties (bending, compression, ten-
sile, shear strength and elastic modulus) as a function of degradation time. Bioactive 
glasses have been combined with different biodegradable poly (α-hydroxyacids) like bi-
oresorbable PLA, poly (glycolic acid) (PGA), and their copolymer poly (lactic acid-co-
glycolic acid) (PLGA). (Langer & Vacanti 1993, Maquet & Jerome 1997, Stamboulis et 
al. 2001 Sherwood et al.2002, Blaker et al.2003, Maquet et al.2003, Maquet et al 2004, 
Lu et al.2002, Li et al. 2005, Niemelä et al. 2005, Niemelä et a.l 2008, Niiranen et al. 
2004, Paivaa et al. 2006, Lehtonen et al. 2012, Gough et al.2003, Roether et al. 2001). 
The combination of such polymers with a bioactive component takes advantage of the 
osteoconductive properties of bioactive glasses and of their strengthening effect on poly-
mer matrices. The composite is expected to have superior mechanical properties than the 
neat unreinforced polymer and to improve structural integrity and flexibility over brittle 
glasses for eventual load-bearing applications. (Maquet et al. 2004)  In addition, several 
studies have also been made on β-tricalcium phosphate (β-TCP) and biodegradable poly-
mer composites. (Niemela et al. 2008, Ahola et al. 2013).  
2.4.1 Porous bioactive glass/polymer composites 
Maquet et al. (2003, 2004) studied the in vitro study of highly porous poly (D, L-lactide)/ 
Bioglass® composites scaffolds and porous poly (α-hydroxyacid)/ Bioglass® composite 
foam that were prepared by freeze-drying. Two series of composite scaffolds made of 
PDLLA and PLGA were prepared by adding different amounts of the Bioglass® (10, 25 
and 50 wt. %) in the mixture. In vitro degradation test was done for 78 days in Phosphate 
based buffer (PBS). It was observed that the water absorption was increased with the 
increase in Bioglass® content. The PLGA/ Bioglass® composites adsorbed larger amount 
of water (~600%) than PDLLA/Bioglass® composites which confirmed that the PLGA 
based composite are more hydrophilic as compared to PDLLA based composite. It was 
found that the compressive modulus of the composites was significantly improved by the 
Bioglass®. The compression modulus of both PDLLA/Bioglass® and PLGA/Bioglass® 
composites foams was significantly higher than that of the neat polymer foams. The pol-
ymer molecular weight, determined by size exclusion chromatography, was found to de-
crease more rapidly and to a larger extent in absence of Bioglass®. The presence of the 
bioactive filler found to delay the degradation rate of the polymer as compared to the neat 
polymer foams. The formation of HA on the surface of polymer/ Bioglass® composites 
was confirmed by both X-ray diffraction and Raman spectroscopy. (Maquet et al. 2003, 
2004). Similar types of results have been reported by Bocaccini and Maquet (2003). 
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Similarly, Lu et al. studied the porous composite of polylactide-co-glycolide (PLAGA) 
and 45S5 bioactive glass (BG) that is biodegradable, bioactive, and suitable as a scaffold 
composite. Structural and mechanical properties of PLAGA-BG were found to be better 
than PLGA alone. The addition of bioactive glass granules to the PLAGA matrix resulted 
in a structure with higher compressive modulus than PLAGA alone. The PLAGA-BG 
composite was found to be a bioactive material, as it formed HA deposits at its surface 
when immersed in a simulated body fluid (SBF), and in the presence of cells and serum 
proteins. (Lu et al. 2002). 
Also, Li et al 2005 studied the porous polyhydroxybutyrate-polyhydroxyvalerate 
(PHBV)/bioactive glass (PHBV/BG) composite scaffolds that were prepared by compres-
sion molding, thermal processing, and particulate leaching method. The in vitro degrada-
tion test showed that water absorption was increased with addition of bioactive glass 
which resulted in more weight loss due to the dissolution of bioactive glass particles. 
Also, the addition of BG to the PHBV matrix resulted in a structure with significantly 
higher compressive yield strength than that of the pure PHBV. The rapid formation of 
apatite on composite scaffolds after 3 days of incubation in SBF indicated the high bio-
activity of the composites. As it is known that the degradation rate of temporary scaffolds 
must be matched to the rate of new tissue formation for tissue engineering and tissue 
repair applications and this study show the possibility to modulate the degradation rate of 
composite scaffolds by incorporation of BG into the polymer matrix. 
2.4.2 Bioactive glass coated composites 
Polymer/bioactive glass composites can also be prepared by coating the polymer with 
bioactive glass. Stamboulis et al. (2001), have studied the effect of bioactive glass coating 
on commercially available Polyglactin 910 (Vicryl®) sutures. Bioactive glass was coated 
by layer-pressing procedure. The resulted coating was not homogenous as expected. 
However, bioactive glass coating was supposed to alter the mechanical properties as w 
ell as it was expected to act as protective layer for polymer slowing down the degradation 
rate.  
Similarly, Gough et al. (2003), studied the polymer/bioactive glass composite prepared 
by coating PDLLA foams by Bioglass® by using aqueous slurry-dipping technique. The 
formation of crystalline HA was formed on the Bioglass® coated PDLLA foams after 7 
days of immersion in SBF. HA was also on the surfaces of non-coated PDLLA foams, 
however the rate and amount of HA formation were much lower than in the composites. 
The rapid formation of HA on the Bioglass®/PDLLA foam surfaces confirmed the high 
bioactivity of these materials. Also, Osteoblasts cell was found to be attached within the 
porous network throughout the depth of the foams. Cell density was found to be higher 
in the PDLLA/ Bioglass® composites compared to the pure PDLLA foams. Hence, it was 
confirmed that the composite foams developed exhibited the required bioactivity to be 
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used as scaffolds for bone tissue engineering. Similar study has been made by Roether et 
al. (2001). 
 
2.4.3 Dense Polymer/bioactive glass composites 
  
Paivaa et al.(2006) studied the in vitro behavior of Bioactive Glass/polyhydroxybutyrate 
Composite. The main aim of this work was to evaluate the in vitro bioactivity of bioactive 
composite. The in vitro tests were conducted for two different weight percentage of pol-
ymer/bioactive glass composites i) bioactive glass/PHB 30/70 wt. % and ii) bioactive 
glass/PHB 40/60 wt. % in SBF for 14 days. In vitro studies show that Bioglass®/PHB 
composites (30/70 wt. % and 40/60 wt. %) have formed a layer of Ca-P. It was suggested 
that these composites have enough bioactivity to be used as biomaterial. The composites 
Bioglass®/PHB 30/70 wt. % form a Ca-P rich layer faster than Bioglass®/PHB 40/60 wt. 
%. The Ca-P layer formed on Bioglass®/PHB 30/70 wt. % has a Ca/P ratio of approxi-
mately 1.67, which is the Ca/P ratio of HA. The quantity of bioactive glass and the size 
of particles influence the bioactivity of composite. It was observed that larger particles 
and high quantity of particles presented less bioactivity than composite with smaller par-
ticles and intermediate size particles. (Paivaa et al.2006) 
Niiranen et al. (2004), studied the self-reinforced bioabsorbable polymer/bioactive glass 
composites in a phosphate-buffered saline for 87 weeks. Addition of bioactive glass 13-
93 on PLLDA, increased the hydrophilic nature of the composites by glass/matrix inter-
faces and promoting the macropores in the structure of the composites at die-drawing. 
However, the faster WA of the composites did not accelerate the degradation of the pol-
ymer matrix according to the decrease in molecular weight and the increase in crystallin-
ity. 
Similarly, Lehtonen et al. (2012) studied the in vitro degradation of three bioresorbable 
glass fiber-reinforced poly(L-lactide-co-DL-lactide) (PLDLA) composites in simulated 
body fluid (SBF and deionized water for 52 weeks. The degradation mechanism was 
found to be a combination of surface and bulk erosion and does not follow the typical 
core-accelerated degradation mechanism of poly(α-hydroxyacids). It was found that 
strength retention by bioresorbable glass fiber-reinforced PLDLA composites can be tai-
lored by altering the the composition of the glass fibers. In addition, the strength retention 
properties of resorbable composites depends upon the selection of matrix type in terms of 
molecular weight and hydrophobicity as well as on processing method. 
Niemelä, (2008), studied the in vitro behavior of self-reinforced composite of PLA matrix 
(Poly-L/DL-lactide 70/30 and Poly-L/DL-lactide 96/4) and spherical bioactive glass 13-
18 
93(BaG) particles filler in Phosphate based buffer for 102 weeks. The cylindrical compo-
site rod was prepared by twin-screw extruder. During the in vitro test series, it was ob-
served that initial mechanical properties were affected by amount of filler. With an in-
crease in filler content, the mechanical properties were found to decrease faster upon im-
mersion in physiological medium. The sample proved to be bioactive if the BaG content 
was between 20-40% which have a large number of open pores in the surface for the rod 
like sample with enough CaP precipitation. It showed that bioactivity of sample depends 
upon number of open pores which depends upon filler content. Enough porosity was not 
observed in case of 10% and 50% containing BaG sample, hence they are not bioactive 
enough to be used in medical application. Also, Niemela found that the addition of oste-
oconductive filler in the polymer matrix increases the amount water absorbed by the sam-
ple because of porous structure of sample, more water could penetrate into the sample. 
This could be because of weak interlocking between BaG and polymer matrix as well as 
by higher porosity of sample containing BaG. 
The addition of osteoconductive filler material like BaG maintained the pH of buffer so-
lution for longer time. This could probably due to releasing of alkaline ion from BaG in 
the surrounding buffer which bind to the hydrogen ion from solution and thus acts as 
alkali, neutralizing the acidic degradation product of PLA resulting in constant pH for 
longer time. (Niemelä, 2008) Similar result has been observed by Lu et al. (2002) during 
the in vitro study of biodegradable polylactide-co-glycolide (PLAGA) and 45S5 bioactive 
glass (BG) composite. During the hydrolysis reactions, PLAGA degrades into glycolic 
and lactic acid, the release of which can cause a biologically significant decrease in local 
pH. Through dissolution reactions, BG releases alkaline ions, which produce an elevated 
local pH. By forming a composite of PLAGA and BG, the acidic byproducts produced 
during polymer degradation and the alkalinity due to the release of alkaline and alkaline 
earth ions maintained the physiological pH up to 3 weeks of culture.  
2.4.4 β-Tricalcium Phosphate/biabsorbable polymers 
Niemela et al. (2005), studied the effect of β -tricalcium phosphate addition on the in vitro 
degradation of self-reinforced (SR) poly-L, D-lactide in PBS for 104 weeks. During the 
in vitro test series, it was observed that addition of β-TCP in polymer matrix affected the 
strength retention. The sample containing β-TCP retained their mechanical properties 
longer than plain matrix polymer. This could probably be due to better mechanical inter-
locking of β-TCP with polymer matrix. The initial mechanical properties of the SR-com-
posites were lower compared to the SR polymer, but the degradation was slower in terms 
of mechanical properties, mass loss and molecular weight of the samples and the pH of 
the buffer solution. 
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Similarly, Ahola et al. (2013) also studied the in vitro behavior of composites of poly (L-
lactide-co-ε-caprolactone) 70/30 and beta-tricalcium phosphate which were manufac-
tured using extrusion to form biodegradable composites. The hydrolytic degradation of 
the composites containing 0, 10, 20, 35 and 50% of β –TCP was studied in vitro for 52 
weeks in phosphate based buffer solution. During in vitro study, it was observed that β -
TCP had a slight effect on the degradation properties which was mainly seen in the water 
absorption behaviour, as β -TCP dissolution was very slow in comparison with the copol-
ymer degradation. However, mass loss and water absorption behaviour were significantly 
changed at 12 weeks in vitro. It was found that the mass loss of the plain copolymer was 
fastest while the mass loss of the composite containing 50% of β -TCP was slowest. This 
was attributed to the fastest dissolution rate of the polymer compared to β –TCP. The 
authors also observed that at short immersion time (less than 12 weeks) the composite 
containing the most β –TCP exhibits the highest water uptake. This was attributed to the 
hydrophilicity of the ceramics particles. However, at longer immersion time, it was as-
sumed that the degradation of the polymer through chain scission led to a polymer more 
prone to absorbed water than the β –TCP. Thus was thought to explain the reason for 
increased water uptake in the plain polymer and low ceramic containing composite.  
During the in vitro test, Ahola et al. (2013) found that the pH of the buffer was very stable 
in the first weeks of the test series. After 10 weeks, pH values were decreased which may 
be due to the acidic degradation products of the polymer degradation that were released 
to the hydrolysis medium. Throughout the in vitro test series, a tendency of increasing pH 
value towards the composites with higher β -TCP contents were observed. This was likely 
due to the release of Ca from the ceramic particles.  
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3. MATERIALS AND METHODS 
 Preparation of glass/polymer composite 
Medical grade PLDLA 70/30, batch number D150400013 with inherent viscosity 4.10 
(dl/g) was obtained from Boehringer Ingelheim Pharma KG, that was supplied by Evonik 
Nutrition & Care GmbH, Darmstadt, Germany. Both Sr50 and 13-93 bioactive glass pow-
der of size 125-250 µm were prepared in laboratory. Glass 13-93 was melted from batches 
containing mixtures of sand (99.4 % pure SiO2), and analytical grades of Na2CO3, H3BO3, 
CaCO3, K2CO3 and CaHPO4.2H2O. The glasses were melted in air in a platinum crucible 
at temperature 1400oC. Glass Sr50 was melted from batches containing NaPO3, Ca(PO3)2 
and Sr(PO3)2. The composition of 13-93 bioactive glass and Sr50 bioactive glass are 
presented in Table 1 below. 
Table 1: Showing composition of bioactive glasses 
Glass type Name Composition 
Silicate 13-93  53SiO2-6Na2O-2K2O-5MgO-CaO-4P2O5 
Phosphate Sr50  50P2O5-10Na2O-20CaO-20SrO. 
 
Before melt extrusion, both glass and PLA was dried thoroughly for 8 hours at 80 °C in 
vacuum. The polymer material should be dried in order to make it free from moisture as 
presence of moisture may lead to the polymer hydrolytic degradation.  
Dried semi-crystalline PLA polymer and 13-93 powder (125-250 µm) were processed 
into rod-shaped composite with a diameter of approximately 2.2 mm with a co-rotating 
custom-built intermeshing twin-screw extruder (Mini ZE, 20*11.5 D, Neste Oy, Porvoo, 
Finland) under nitrogen atmosphere. Total amount of polymer used was 600 grams and 
total amount of glass used was 100 grams. The feed rate for polymer and glass was varied 
to obtain 10, 30 and 50 wt. % of glass in the polymer. To maintain the glass-containing 
polymer melt viscosity constant the temperature of the extruder was varied depending on 
the glass content as shown in Table 2. 
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Table 2: Extrusion temperatures and weight for preparing polymer/glass composites 
Sample 
name   
Tempera-
ture (°C) 
Zone 1  
Tempera-
ture (°C) 
Zone 2  
Tempera-
ture (°C) 
Zone 3 
Tempera-
ture  (°C) 
Zone 4 
Feed rate 
of poly-
mer g/h  
Feed rate 
of glass 
g/h  
PLA  180 178 197 203  100 -  
PLA+10% 
13-93   
174  172 191  197 108 12  
PLA+30% 
13-93   
171  169  188  195  126  54  
PLA+50% 
13-93   
171  169  188  195  150  50  
PLA+10% 
SR50   
186 180 201  206 108  12  
PLA+25% 
SR50   
197 193 212 217 126  54  
PLA+35% 
SR50   
194 192 209 214 150  50  
 
PLA and glass were fed with separate gravimetric screw feeders and the mixing of the 
components took place in the extruder. A caterpillar belt was used to guide the composite 
rods from the die and the diameter of the composite rod was controlled by adjusting the 
speed of the belt. The speed of the belt was set to 10 meters per minute. The composites 
containing silicate glass are denoted as PLA+ 10% 13-93, PLA + 30% 13-93, PLA + 50% 
13-93. Similarly, other types of composites containing phosphate glass were denoted as 
PLA+ 10% SR50, PLA + 25% SR50, PLA + 35% SR50. The approximate diameter of 
composite rod obtained was 2.2 mm. The composite rod was cut at 1-meter length for 
each and at least 6 meters of composite rod was selected for each composite. The rods 
were then cut to 70 mm length for hydrolysis test. 
 Preparation of TRIS Buffer 
To prepare the TRIS buffer, 400 ml of distilled was taken in a beaker and was left to stir 
with magnetic stirrer for 15 minutes. Then, required amount of TRIS HCL and TRIS base 
as mentioned in table 3 was added slowly to the solution. The solution was allowed to stir 
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for 15-20 minutes until it become homogenous. When, the solution become homogenous, 
the beaker was removed from stirrer and was kept in water bath set to 37°C for an hour. 
Then, the pH of the solution was measured by a pH meter (Mettler-Toledo GmbH, 
Schwzebbach, Switzerland). pH meter was calibrated before measuring the pH. And the 
measured pH of solution was between 7.35-7.39 at 37° C. The prepared solution was 
transferred to a 1 litre round bottom flask and 600 ml of distilled water was added. TRIS 
buffer was always stored in freezer before use.  
Table 3: Chemical used to prepare TRIS 
Reagent Amount (mg) Manufacturer 
Trizma Base 1.66 Sigma Aldrich 
Triszma Acid 5.70 Sigma Aldrich 
 In vitro Hydrolytic test 
For in vitro test, the estimated length of the sample was 70 mm. For each test point, 3 
parallel samples were used. All the samples were weighted before immersion test to get 
the initial dry weight of the samples. The amount of TRIS buffer was calculated according 
to International Standard ISO 15814 for in vitro degradation testing (volume/weight ratio 
was greater than 30:1 ml/g). As average weight of our sample was 0.4 g, the estimated 
amount of buffer to be used in in vitro test was 12 ml. and the immersed samples were 
placed in shaking incubator at 37°C. The buffer was changed every two weeks. The in 
vitro test was done for 24 h, 48 h, 72 h, 1 wk, 2 wk, 4 wk and 6 wk. Test samples were 
withdrawn at predetermined time point. At each time point, pH measurement, wet weight 
measurement, dry weight measurement, mechanical testing (bending and shear), Gel Per-
meation Chromotography (GPC), FTIR and AAS were carried out. 
 Differential Thermal Analysis 
The glass content of the test samples was measured using Differential Thermal Analysis 
(NETZSCH, Leading Thermal Analysis, STA 449F1). All tests were performed in alu-
mina (Al2O3) crucible and in N2 atmosphere. Approximately, 20 mg of sample was used 
and samples were heated from 25°C up to 1000°C. The heating rate was 10°C/min. The 
results were analyzed by using Proteus Analysis software. Two parallel samples were 
analyzed for each type of polymer/glass composition.  
 Mass loss and water absorption 
The dry weight of each samples was taken prior to immersion test. At each time points, 
the samples were carefully wiped with tissue to remove excess water. Each of the test 
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samples were weighed immediately after wiping in order to obtain the wet weight of sam-
ple. Successively, the samples were cleaned with ethanol to dry the sample and stop the 
hydrolysis reaction and the samples were allowed to dry for one week in vacuum. After 
vacuum drying, each samples were weighed again to obtain their dry mass. Dried test 
samples were stored in a desiccator in view of their mechanical testing.  
The mass loss was calculated as the difference between the mass of the initial test sample 
and the mass of the dried test sample divided by the initial mass of the test sample. Sim-
ilarly, the water absorption (WA) was calculated as the difference between the mass of 
the wet test sample and the mass of the dried test sample divided by the mass of the dried 
test sample. 
 
Mass Loss (%) =
dry weight − initial weight
initial weight
×  100% (𝑖) 
WA (%) =
wet weight − dry weight
dry weight 
×  100% (𝑖𝑖) 
 
 Mechanical testing (bending and shear test) 
The mechanical testing was done for all composite. All tests were done in triplicate. The 
mechanical testing was conducting prior and after immersion test. The purpose of the test 
was to ascertain the initial mechanical properties of composites as a function of glass 
composition and glass content, as well as to as a function of immersion time. The dry 
samples were mechanically tested at room temperature by three-point bending and shear-
ing using Instron 4411 mechanical testing apparatus (Instron Ltd. High Wycombe, Eng-
land). 
The three-point bending test was done according to the standard SFS-EN ISO 178 Plastics 
- Determination of flexural properties. (SFS-EN ISO 178 2011). The diameter of the test 
samples was measured with a slide gauge. And shear test was done using Standard BS 
2782 method 340B (1978). After mechanical testing, all the sample pieces were collected 
and placed in dessicator for further analysis. The average values and standard deviations 
were calculated. All samples were measured in triplicate. Parameter used at three-point 
bending and shear test can be seen in table 4 below: 
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Table 4: Parameters for 3 point bending and shear test 
Parameter Bending Shear 
Load cell  500 N 500 N 
Crosshead speed 5 mm/min 10 mm/min 
Radius (loading edge) 1.5 mm - 
Length (bending span) 32 mm - 
 Gel Permeation Chromatography 
For GPC analysis dry samples were used. The estimated weight for GPC sample was 
calculated to be 7.35±0.15 mg for the plain polymer. The mass of sample was adjusted 
taking into consideration the mass of glass presents in the sample to be studied. The sam-
ples were dissolved overnight in 5ml of chloroform (chromasolv for HPCL, ≥ 99.8%) 
obtained from Sigma Aldrich and glass particle is filtered in order to analyze the molec-
ular weight of polymer only. HPLC Filter (GHP Acrodisc 25 mm Syringe Filter with 0.2 
micrometer GHP membrane) obtained from Life sciences were used during the GPC pro-
cess. 
 Atomic Absorption Spectrometry  
For Atomic absorption spectrometry (AAS) test, 5 ml of the immersing solution was col-
lected and diluted to 50 ml with deionized water. The solution was stored in freezer until 
the test was performed. AAS was performed in Perkin Elmer absorption spectrometer to 
quantify the calcium concentration in the solution. The equipment was calibrated with 
four different standards containing 1.0, 1.5, 2.5 and 5 mg/L of Ca2+. TRIS was used as 
blank. The slope and correlation coefficient were calculated for the calibration curve and 
are presented in table 5 below: 
Table 5: Showing slope and Correlation Coefficient of blank 
Test Sample Slope Correlation coefficient 
Blank 1 0.07853 0.99688 
Blank 2 0.07563 0.99482 
 Fourier transform infrared spectroscopy 
Fourier transformed infrared spectroscopy (FTIR) was performed using Perkin Elmer 
Spectrum one FTIR spectrometer in Attenuated Total Reflectance (ATR) mode to deter-
mine the structural changes occurring in the composite upon immersion. The resolution 
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used was 2 cm-1, and the spectra was obtained from the accumulation of 4 scans. All 
spectra were baseline corrected and normalized to the band with maximum intensity.  
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4. RESULTS AND DISCUSSION 
 Thermogravimetric Analysis  
Thermogravimetric Analysis (TGA) was performed post-processing and prior in vitro test 
in order to estimate the filler content in the test sample. Figure 6 shows the TGA curve 
for PLA+10% 13-93, taken as an example. As PLA is very sensitive to temperature, ther-
mal degradation of polymer occurs during the TGA test. Thermal degradation of poly-
mers starts from 320 °C and polymer degrades completely at 400°C, as seen by steep 
weight loss, thereby leaving the glass residue as shown in Figure 6.  
 
 
Figure 6: Thermal degradation of composite 
The glass residue represents the actual amount of glass particles in the composite sample. 
In Table 6 are compiled the actual filler content for all the tested samples. The obtained 
values are the average of two parallel samples. For composites containing both silicate 
and phosphate glass, the filler content was found to be close to the expected one and 
within the accuracy of the measurement. However, it was note-worthy to state that alt-
hough feed rate of glass and polymer was same for both phosphate and silicate based 
composites as can be observed from Table 2, resulting composites have different amount 
of filler content. Equal amount of filler content was observed in both phosphate and sili-
cate based composites that were loaded with 10 % bioactive glass. While the filler content 
for phosphate based composites was significantly lower for the samples with higher par-
ticles loading than silicate based composites. One of the possible reason could be that 
phosphate glasses typically have higher density than silicate glass.  Introduction of Stron-
tium oxide (SrO) into the glass causes an increase in density that correlates well with the 
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SrO concentration (Abou Neel et al. 2009) The higher density can lead to faster precipi-
tation of the glass at the bottom of the extruder, resulting in lower amount of filler in the 
test sample than expected despite of same federate used during the extrusion process. 
Another, source of error could be the small sample size used in the TGA. Indeed, the 
sample tested was about 20 mg and the particles was 125-250 µm. an alternative test that 
could be conducted is a burning test.  
 
Table 6: Expected and experimental filler content in PLA (in wt. %). Two parallel sam-
ples were used for each polymer/bioactive glass composition. 
Composites Expected glass wt. % Obtained glass wt.% S.D. 
PLA+ 10% 13-93 10 11 0.7 
PLA+ 30% 13-93 30 33 1.4 
PLA+ 50% 13-93 50 51 0.7 
PLA+ 10% SR 50 10 12 0.7 
PLA+ 25% SR 50 25 23 0.7 
PLA+ 35% SR 50 35 34 1.4 
 In vitro pH changes 
Rods of 70 mm in length and 2.2 mm in diameter were immersed in TRIS buffer solution 
for 6 weeks. The solution was changed every two weeks and thus after changing the so-
lution pH was 7.36 at 37 °C as indicated by horizontal line in Figure 7 and Figure 8. The 
pH of the buffer solution was recorded as a function of immersion time and is presented 
in Figure 7 for the PLA/silicate glass composite and Figure 8 for the PLA/phosphate glass 
composite. 
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 Figure 7: pH changes of buffer due to silicate based composite. Each point represents 
the average of three parallel samples. 
 
In the case of PLA/silicate glass composite, the pH slightly decreased with time, in the 
case of the composite filled with 10 wt. % of bioactive glass. However, with an increasing 
the glass content an increase in the pH was seen. This increase in pH is found to be higher 
after the first 2 weeks of immersion. The rise in pH was less at the 4 weeks and negligible 
at 6 weeks of immersion. Silicate bioactive glasses are known to react in physiological 
media by first exchanging H+ ions with Na+ ions and then Ca2+ is leached out. The release 
of alkali and alkaline earth ions lead to an increase in the pH. (Hench et al. 2004) The 
decrease in the pH seen for the 10 wt. % containing composite, may be due to the early 
degradation of the PLA. However, change in pH is typically reported to occur at later 
immersion time (Niemelä, 2010, Lu et al. 2002). Early degradation of the polymer may 
occur due to water accumulation at the glass/polymer interface. The lower pH change 
after the first 2 weeks of immersion may be due to either 1) decreased glass degradation 
over time or ii) contemporaneous glass (basic) and PLA (acidic) dissolution which in 
turns will lead to pH stabilization. 
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Figure 8: pH changes of buffer due to phosphate based composites. Each point represents 
the average of three parallel samples. 
 
For phosphate glass based composites, pH was observed to decrease for all samples al-
ready at 24 hours. With an increase in the phosphate content the decrease in pH was 
greater, especially at the 2-week time point. Decrease in pH is expected in the case of 
phosphate bioactive glass dissolution. Indeed, upon dissolution, phosphate glasses leach 
out a large amount of phosphate which in aqueous solution forms phosphoric acid. Similar 
result has been observed by Georgiou, et al. 2006, while studying the in vitro test of 
PLA/phosphate glass composite foam. However, different dissolution media, for example 
deionized water was used in that case. The release of PO4 
3- was more prominent relative 
to the cations, indicating a rapid breakdown in the phosphate network of the glass. The 
release of PO4 
3- increased significantly with glass content.  
Furthermore, Bunker et al. proposed that phosphate glasses dissolve in two stages. The 
first stage is controlled by the rate at which water diffuses into a volume of the bulk glass 
surface. This kinetics is obeyed only until the polymer chains at the surface are entirely 
surrounded by water. Totally hydrated chains can then disentangle from the partially hy-
drated chains still attached to the surface and float off into solution resulting in uniform 
glass dissolution and kinetics that are linear with time. Bunker et al. also mentioned that 
phosphate chain ends can be interconnected by hydrogen bonding which reduces the deg-
radation rate (Bunker et al.1984).  The decrease in pH was found to occur at every two 
weeks’ time points, after the buffer has been refreshed. It is noteworthy that typical phos-
phate glass does not generally induce such drastic decrease in pH (Massera, et al. 2012). 
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Thus it is reasonable to think that the accumulation of aqueous solution at the glass /PLA 
interface, which has a locally low pH due to the degradation of the glass further increased 
the PLA degradation which in turn leads to a more drastic pH drop. In contrary, no sig-
nificant degradation of PLA was observed while doing in vitro test of β- TCP/PLA96 
even upon up to 68 weeks, that would result in decrease in pH from the acidic degradation 
of PLA as observed in this study. (Niemelä et al. 2005). Similar result was obtained by 
Ahola et al. (2013). Hence, it should be noted that degradation behavior of polymer is 
highly dependent upon the types of buffer that have been used in in vitro test.  Most of 
the polymer/bioactive glass composites that have been studied so far was done in PBS 
buffer which showed different degradation effect in polymer than TRIS buffer that is used 
in this thesis. So, in-depth study of degradation of polymer/bioactive glass in different 
dissolution medium might help to know the degradation phenomenon of polymer. 
 Water Absorption 
Upon immersion in the TRIS buffer solution, the samples were found to swell as seen in 
Figure 9 which shows a photograph of the PLA/phosphate glass composite prior and after 
immersion. This indicates that the composite is retaining the solution. The swelling of the 
samples was also found to be a function of the filler content.  
 
 
Figure 9: Visual Characterization of phosphate based composites. (a) PLA+10%SR50 
(left 0wk right 6 wk) (b)PLA+25%SR50 (left 0 wk right 6 wk) (c) PLA+35%SR50 (left 
0wk right 6 week)  
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The water absorption was further quantified using the equation (i) and (ii) presented in 
chapter 3. The Figure 10 below shows water absorption, in %, for silicate based compo-
sites 
 
 
Figure 10: Water absorption by silicate based composites. Each points represents the 
average of three parallel samples. 
 
From Figure 10, we can observe that WA increased for silicate based composite. Maxi-
mum water absorption was observed for PLA+10% 13-93 in 1 day which was surprising 
as for all other composites, WA was increased with filler content and upon increase in 
immersion time, this obtained result might be due to the measurement error for example 
improper calibration of weighing scale or composite samples were not wiped as carefully 
as it should be for these samples. However, accurate reason for the steep increase in WA 
at day 1 is not yet fully understood. WA was decreased at 3 days, after that WA was 
slowly increasing up to 6 weeks. Maximum water absorption was observed in PLA+ 
50%13-93 which may be due to the large amount of filler content in it.  Indeed, an increase 
in filler content will lead to larger glass/polymer interface, site at which the water is more 
likely to be retained. Figure 11 shows the water absorption in phosphate based composite.  
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Figure 11: Water absorption by phosphate based composites. Each point represents the 
average of three parallel samples. 
 
 
All sample started to uptake water as soon as they are immersed in the buffer for 1 day. 
The WA increased gradually with an increase in immersion time. The maximum uptake 
of water was seen in PLA+35% SR50 and, in general, the WA increased with increasing 
filler content. Hence, it was confirmed that WA increases with increase in filler content. 
This is because porosity of sample increases with increase in filler content where water 
gets more space to be absorbed.  
Water absorption in silicate based composite was significantly lower in comparison to 
phosphate glass containing composite. This may be due to the large number of OH- group 
at the silicate glass surface (Hence, 1991). The presence of OH- group in glass are likely 
to increases the adhesion between polymer matrix and glass The lower amount of OH- 
group at the surface of phosphate glasses results in weaker mechanical interlocking be-
tween polymer matrix and glass. Such that interfaces between matrix polymer and filler 
particles enables more water to penetrate the structure resulting in increased water ab-
sorption.  
Niemelä, et al. (2010), also observed that the addition of osteoconductive filler increased 
the water absorption of the composites at the very early stage of hydrolysis in all sample 
studied which may be due to the presence of large number of porous structure that allowed 
more water to penetrate through the interface between polymer matrix and filler particles. 
Increase in both surface and interior porosity will be advantageous for bone tissue in-
growth. (Kellomäki et al. 2000). It was reported that composites containing 13-93 bioac-
tive glass absorbed more water than composite containing β- TCP which may be due to 
large number of pores that were formed on the surface of composite with 13-93 bioactive 
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glass due to self-reinforcing process. (Niemelä, et al. 2010). Similar increase of water 
absorption was observed in other polymer/bioactive glass composites. (Niiranen et.al 
2004, Maquet et al. 2004). Boccaccini and Maquet, (2003), also observed rapid increase 
in water up take by polymer/bioactive composites during first week of incubation. How-
ever, WA reached saturation level at 21 days and WA was gradually decreased. 
 Mass Loss 
The mass loss for silicate based composite is presented in Figure 12. Up to 72 h of im-
mersion, no significant mass loss could be recorded. For longer immersion time the mass 
loss increases for the composites containing 30 and 50 wt. % of silicate glasses whereas 
is remained unchanged for the composite containing the lowest filler content. Figure 13 
presents the mass loss of the composites containing phosphate bioactive glasses as a func-
tion of immersion time. 
 
Figure 12: Mass Loss of silicate based composites sample. Each point represents the 
average of three parallel samples. 
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Figure 13: Mass loss of phosphate based composites. Each point represents the aver-
age of three parallel samples. 
 
For Phosphate based composite, no significant mass loss was observed up to 2 weeks. 
After 2 weeks, there was a dramatic increase in mass loss with increase in immersion 
time. The mass loss was also found to increase with increasing the filler content. As can 
be observed from the Figure 13, maximum mass loss was observed at 4 weeks for com-
posite containing 25% and 35% of glass and appear to level of for 6 weeks’ immersion 
time.  
It was observed that mass loss in composites sample containing silicate glass was slower 
in comparison to sample containing phosphate glass. At the longest immersion time, the 
mass loss of phosphate containing PLA was at least two times higher than its silicate glass 
containing PLA counterpart. Mass loss in phosphate glass was higher due to weak inter-
locking between polymer and phosphate glass. The P–O–P bonds between the [PO4] units 
breaks under the attack of H+ ions and water molecule, resulting in the destruction of glass 
network and disentanglement of short-chain polyphosphates into solution with different 
degree of polymerization. As the network breakage reaction of phosphate glass is highly 
sensitive to the attack of H+ ions that usually decreases the pH value of aqueous media. 
Decrease in pH of aqueous media could certainly increase the dissolution rate of the phos-
phate glasses, resulting in rapid mass loss. (Gao et al. 2003) 
The addition of β- TCP and 13-93 bioactive to self-reinforced samples reduced the overall 
degradation of composites in term of mass loss. Mass loss was observed at very beginning 
of immersion test for 13-93 bioactive glass based composite which may be due to rapid 
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dissolution of silicate glass while for β- TCP based composites, mass loss was observed 
at later stage. However, significant mass loss was started to observe after 52 weeks. (Nie-
melä, et al. 2010). The mass loss was more pronounced until 48 weeks. The greater WA 
at the early stage of immersion probably induced the degradation of self-reinforced com-
posites in terms of mass loss. (Niiranen et al. 2004) 
 Atomic Absorption Spectroscopy  
The Ca+ release, which is an indication of the glass dissolution, was quantified by AAS. 
Figure 14 presents the cumulative dissolution of calcium ion up to 6 weeks for both sili-
cate and phosphate bioactive glass containing PLA rods. The release of Ca+, was in-
creased with increasing immersion time and filler content in both case.  Ca+ release was 
found to be higher for silicate glass based composite than phosphate glass based compo-
site. This is because the dissolution of bioactive silicate glasses is primarily governed by 
the leaching of alkaline and alkaline earth ions within the solution while the Si is leached 
at lower rate forming a Si-rich gel. In the case of phosphate bioactive glasses, all ions in 
the glass network leach out at a similar rate and the surface of the glass does not change 
significantly its composition. As no gel layer is formed, the dissolution of phosphate 
based glass is more sustained. (Massera et al. 2012) Furthermore, it is likely that the dis-
solution rate of the silicate glass is higher than in the case of the phosphate one. Another 
eventuality for the lower Ca release in solution from the phosphate glass containing com-
posite could be that, due to the higher P release the Ca is more likely to bind to P ions to 
form and precipitate a CaP layer. 
 
 
Figure 14: Calcium release profile. Each point represents the average of at least two 
parallel samples. 
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 Mechanical Testing 
4.6.1 Bending Test (3 Point bending test) 
The 3-point bending test was done for all 0 week as well as in vitro test samples. All the 
0-week test sample were found to be brittle which was attributed by the brittle nature of 
glass. The brittleness of sample was found to be increased with increase in filler content. 
Similar result was obtained for PLA/bioactive glass composites. Sample became weaker 
and brittle with the increase of filler material. In order to improve initial mechanical prop-
erty of sample and to decrease the brittleness of the composites self-reinforcing was done. 
(Niemelä, 2005). Silicate containing composites sample have highest initial bending 
strength (116 MPa) which can be observed in Figure 15. The bending strength decreased 
with in vitro test up to 2 weeks which is due to the degradation of composite especially 
degradation of glass for all in vitro test samples. Fastest decrease in bending strength was 
observed for PLA+50% 13-93. At the same time, test sample started to become ductile 
from brittle which is probably due to formation of HA layer on the surface of test samples. 
At 4-week test point, the bending strength increased drastically which was not expected. 
The result of bending strength was surprising at 4-week time point. The increase in bend-
ing strength may be due to the formation of HA. Then slight decrease in bending strength 
was observed at 6-week test point. Longer immersion test is required to be conducted to 
studying the mechanical behavior of composite in terms of bending strength. (Niemelä, 
2008) reported result for bending strength of for similar polymer/glass composites which 
was different than here. Bending strength of composites was gradually decreasing from 
117 MPa (0 wk) to 112 MPa till 6 weeks unlike in this study. The dramatic decrease of 
bending strength was observed only after 30 weeks of immersion test.   Bending strength 
of composites was decreased upon increase in immersion time. Also, higher amount of 
filler content resulted in faster loss of mechanical properties of sample. The composites 
lost all of its mechanical strength at 65 weeks.( Niemelä, 2008)   
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Figure 15: Bending Strength of Silicate based composites. Each test points represents 
the average of three parallel samples. 
 
Phosphate based composites also behaved in the similar manner. However, the increase 
in bending strength at 4 weeks is not as significant as in silicate based composites. This 
may be due the reason that HA precipitation in phosphate glass may occur in later stage. 
 
 
Figure 16: Bending Strength of Phosphate based composites. Each point represents the 
average of three parallel samples. 
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4.6.2 Shear Test 
Shear strength did not change significantly over the time for both silicate and phosphate 
based composites. Shear strength was expected to decrease with increase in vitro test. 
Slight decrease in shear strength was probably due to water uptake and / or due to loos-
ening glass particles from the sample. Shear stress was likely to decrease upon increase 
in in vitro test point. .(Niemelä, 2005) Longer in vitro test are required to observe the 
behavior of shear strength over the time. Also, Niiranen, et al. (2004), observed decrease 
in shear strength depends upon immersion time. Further, shear strength was dependent 
upon filler content in the composites. Increase in filler content decrease the shear strength 
of the test samples. 
 
Figure 17: Shear Strength of Silicate and Phosphate based composites. Each point rep-
resents the average of three parallel samples. 
 
 Gel Permeation Chromatography 
Molecular weight plays an important role in degradation of the composites studied. Figure 
18 shows the number average molecular weight (Mn) of polymer. The molecular weight 
distribution of all the test samples were monomodal throughout the whole hydrolysis. 
From Figure 18 below, it can be observed that the molecular weight of polymer decreases 
as soon as it is immersed in buffer. The decrease in molecular weight was started to ob-
serve at 24 hour of immersion time for all test sample. This is due to water diffusing into 
the polymer, especially in polymers amorphous structure. The penetration of water breaks 
the long polymer chain in shorter one resulting in decrease in molecular weight. (Niemelä, 
2005) The molecular weight of silicate based composite decreased up to 2 weeks and 
became almost consistent up to 6 weeks. This may be due to degradation of polymer has 
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become slower. However, for phosphate based composites the decrease in molecular 
weight were drastic in comparison to silicate based composites. After that, the molecular 
weight of polymer gradually increased up to two weeks. There was a dramatic increase 
in molecular weight in context of phosphate based composite than in silicate based sample 
which can be clearly observed from Figure 18 below. The maximum increase of molecu-
lar weight was observed in PLA+ 10% SR50. The results obtained was unexpected as 
increase in molecular weight have not been observed yet for any of the polymer/bioactive 
glass that have been studied so far.  This indicates that Phosphor content on glass has 
great effect on polymer chain which is needs in-deep analysis to interpret the result.  
 
 
Figure 18: Number average molecular weight(Mn) of polymer/bioactive glass compo-
site. Each point represents the average of two parallel samples. 
 
 FTIR  
a) FTIR spectrum of silicate based composite 
FTIR spectrum of PLA is shown in Figure 19. The spectrum presents a strong absorption 
band at 1748 cm-1 which is attributed to the stretching vibrations of amorphous carbonyl 
groups (Furukawa et al. 2007).  The other bands that are observed at 1452 cm-1 and 1382 
cm-1, are due to the CH3 asymmetric and symmetric deformations. The strong absorption 
band located at 1180 cm-1 is due to C-O-C stretching mode, while a shoulder positioned 
at 1210 cm-1 is attributed to C-O-C stretching characteristic for the crystalline phase of 
PLA. (Buzarovska & Grozdanov, 2010) 
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Figure 19: FTIR spectrum of PLA + silicate glass composites(0 week) 
Upon addition of silicate glass, 13-93, the spectrum showed resonances at 1050 and 940 
cm-1 attributed to the stretching vibration modes of Si bonded to non-bridging O in the 
glass network (Fu, et al. 2007). With increasing in the filler content, the band that are 
attributed to stretching vibration of the silica networks broadened. The decrease in peak 
intensity at band 1748 cm-1, 1452 cm-1 and 1382 cm-1 was observed with increase in filler 
content which may be due to the Si replacing the carbonyl group of PLA.  
 
Figure 20: FTIR spectrum of in vitro silicate based composites 
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Figure 20 presents the FTIR spectra of the silicate based composites at various immersion 
time. Upon immersion of composite, no significant change was observed for PLA+ Sili-
cate glass in this figure. The broadband centered at 3400 cm-1 corresponded to O–H band. 
(Fu et al.2013) This absent of this band assures that there was no significant water ab-
sorption observed for PLA+10%13-93 composites.  
b) FTIR spectrum of Phosphate based composite 
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Figure 21: FTIR spectrum of PLA + phosphate glass composites(0 week) 
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Figure 22: FTIR spectrum of phosphate based composite in vitro 
Figure 21 presents the FTIR spectra of the PLA-silicate glass composites. The typical 
FTIR of phosphate glass represents the band at 880 cm-1 is attributed to P–O–P asym-
metric stretching of bridging oxygen. The shoulder centered at 980 cm-1 and the band 
peaking at 1,085 cm-1 correspond to the symmetric and asymmetric stretching vibration 
of PO32-. The band at 1,085 cm-1 can be attributed to an overlap between PO3 and PO2. 
The shoulder at 1,154 cm-1 correspond to symmetric and the absorption band at 1,260 
cm-1 correspond to asymmetric vibration of PO2-. (Massera et al. 2012) However, such 
bands cannot be observed significantly at Figure 21, which may be due to use of non-
uniform sample. Best FTIR spectrum can be observed from powder sample or a thin and 
flat surface which was not the case in the sample that was used in this thesis. 
 
Figure 22 presents PLA-phosphate glass composites. With an increase in immersion time, 
a band at ~2800 cm-1 appears and broaden with immersion. This band that appears from 
2800cm-1 to 3600cm-1 is due to water absorption within the composite structure. Navvaro 
et al. (2005), observed similar bands at 3000-3500 cm-1 region which was due to the water 
uptake by PLA/glass composite. 
 
In conclusion, from the FTIR spectra it appears that composite containing phosphate bi-
oactive glasse are more prone to absorb water during immersion. Whereas addition of 
silicate leads to greater changes in the structure of the polymer itself.   
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5. CONCLUSIONS 
Hence, from above results, it can be concluded that phosphate based composites are likely 
to decrease the pH of the solution due to the formation of phosphoric acid while compo-
site containing silicate glasses are likely to increase pH of solution due to leaching of 
cations in the solution making solution more alkaline. From mass change, water uptake 
measurement and FTIR test, it was clear that the water absorption was increased with 
increase in filler content. The changes were more drastic with the phosphate based com-
posites compared to the silicate one. Calcium release was increased with immersion time 
and the silicate glasses released more Ca+ than the phosphate glass. The release of the 
Ca+ in the solution is a clear indication that the solution will be saturated overtime and 
this is likely to lead to the precipitation of a HA layer.  
 
The mechanical properties of all investigated glasses were found to first decrease, as ex-
pected upon degradation of the composite. However, it was noteworthy that the bending 
strength increased after two weeks of immersion. Such result was unexpected, especially 
since the shear strength was not found to greatly change over the course of the test, and 
calls for more in-depth analysis of the structural changes occurring at the glass and poly-
mer surface upon extended immersion time.  
 
Finally, the molecular weight of the polymer was found to be decreased upon immersion. 
For silicate based composites, molecular weight decreased up to two weeks and remained 
stable for longer immersion time. In contrary, for the phosphate based composite, the 
molecular weight was found to increase drastically after two weeks of immersion, raising 
the question of the impact of P release on the cross linking of the polymer chains.  
 
Hence, we can conclude that degradation of polymer/bioactive glass composite is highly 
dependent on types of matrix, filler (quantity and particles size) and dissolution solution 
that is used for in vitro test. However, optimum amount of filler content is dependent 
upon particular application. Most importantly, longer immersion test is required to fully 
understand the degradation behavior of both polymer and glass from composites as well 
as to observe formation of HA layer on the surface of composites. 
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